← Reviews
Open accessFull analysisJun 16, 2026

Microbiome, Diet and Rheumatoid Arthritis: Narrative Review on Disease Activity and Immune-Inflammatory Status

This narrative review consolidates heterogeneous and predominantly low-quality evidence indicating that dietary interventions and microbiome modulation produce modest favorable effects on inflammatory markers and RA activity, without sufficient data to support precise clinical recommendations.

The question (PICO)
PopulationAdults with established rheumatoid arthritis or at risk; majority of included studies with female predominance
InterventionDietary interventions (Mediterranean, vegan, gluten-free diets; omega-3/EPA+DHA; vitamin D; antioxidants; prebiotics; probiotics) and gut microbiome modulation
ComparatorPlacebo, control diet, no intervention, or healthy controls (varies by primary study included)
OutcomeDisease activity (DAS28), inflammatory markers (CRP, ESR, IL-6, TNF-α), physical function (HAQ), pain (VAS), gut microbiome composition, and NSAID/DMARD requirement
CEvidence
Study
Review
Effect
Favorable
Summary of findings by outcome
OutcomeGradeDirectionEffectStudies
Disease activity (DAS28)C Favorablecorrelação inversa com vitamina D em meta-análises; sem síntese quantitativa agregada7
Inflammatory markers (CRP, IL-6, TNF-α)C Favorableredução relatada com omega-3 e probióticos em RCTs pequenos; sem IC 95% sintetizado
NSAID requirementC Favorableredução associada a omega-3; sem tamanho de efeito quantificado
Physical function (HAQ)C Favorablemelhora associada à dieta mediterrânea em estudos observacionais; sem quantificação agregada
Gut microbiome compositionC Insufficientdados associativos; causalidade não estabelecida; sem síntese quantitativa
Risk of developing RA (vitamin D)C Favorableingestão mais alta de vit D associada a 24,2% menor risco vs ingestão mais baixa; sem IC 95% reportado1
Pain (VAS)C Favorablemelhora reportada com omega-3; sem tamanho de efeito quantificado
Disease activity (DAS28)C
Direction Favorable
Effectcorrelação inversa com vitamina D em meta-análises; sem síntese quantitativa agregada
Studies7
Inflammatory markers (CRP, IL-6, TNF-α)C
Direction Favorable
Effectredução relatada com omega-3 e probióticos em RCTs pequenos; sem IC 95% sintetizado
Studies
NSAID requirementC
Direction Favorable
Effectredução associada a omega-3; sem tamanho de efeito quantificado
Studies
Physical function (HAQ)C
Direction Favorable
Effectmelhora associada à dieta mediterrânea em estudos observacionais; sem quantificação agregada
Studies
Gut microbiome compositionC
Direction Insufficient
Effectdados associativos; causalidade não estabelecida; sem síntese quantitativa
Studies
Risk of developing RA (vitamin D)C
Direction Favorable
Effectingestão mais alta de vit D associada a 24,2% menor risco vs ingestão mais baixa; sem IC 95% reportado
Studies1
Pain (VAS)C
Direction Favorable
Effectmelhora reportada com omega-3; sem tamanho de efeito quantificado
Studies

Context

RA affects 0.5–1% of adults in developed countries, with chronic systemic inflammation, joint destruction, and high comorbidity burden. Environmental factors including diet and gut microbiota modulate relevant immune pathways (NF-κB, IL-23/IL-17 axis, NLRP3 inflammasome). Integration of dietary patterns, microbial composition, and clinical outcomes remains underexplored in high-quality studies.

What the study showed

Omega-3 (EPA+DHA) was associated with reduced NSAID requirement and improved pain across multiple studies; Mediterranean diet showed an association with lower disease activity and better physical function in observational studies. Vitamin D showed an inverse correlation with DAS28 in two meta-analyses (2,885 and 3,489 patients, respectively), but interventional trials are scarce and results inconsistent. Probiotics demonstrated reductions in CRP and IL-6 in some small RCTs, without consistent effect on DAS28. No 95% CI or standardized effect sizes were quantitatively synthesized in the review.

How it was done

Narrative (non-systematic) review published in Nutrients (2026). No PROSPERO registration, no explicit search strategy, no formalized inclusion/exclusion criteria, and no risk-of-bias assessment of primary studies. Includes meta-analyses, RCTs, observational studies, and mechanistic preclinical data without clear separation of evidence grades.

Effect magnitude

No quantitative synthesis was performed; the review did not calculate pooled effect sizes or 95% CIs for any outcome. Clinical magnitude of interventions remains undetermined.

Limitations

Narrative review without registered protocol, no formal risk-of-bias assessment (RoB 2, ROBINS-I, or AMSTAR-2 not applied), non-transparent search strategy, and no meta-regression. Included primary studies have small samples, short duration, female-predominant populations, multicomponent interventions, and heterogeneous outcomes. Reverse causation cannot be excluded for vitamin D. Conflicts between observational and interventional data are not resolved.

In clinical practice

Clinicians may consider Mediterranean-pattern dietary counseling and omega-3 supplementation as adjuncts to pharmacotherapy, acknowledging that current evidence does not support replacing DMARDs. Vitamin D supplementation is reasonable in patients with documented deficiency, but no specific serum target for RA control is supported. Probiotics have no established indication in RA based on available evidence.

What is still missing

Long-duration multicenter RCTs with simultaneous assessment of microbiome, metabolites, and standardized clinical outcomes (DAS28, HAQ, CRP) are needed to establish causal relationships and guide precise dietary recommendations in RA.

Source: DOI 10.3390/nu18091325 · 2026

Microbiota Weekly

The week in microbiota evidence, in your language. Structured summaries, traceable to the source.